Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-694,200
Closed -$21M 5725
2025
Q4
$21M Sell
694,200
-253,400
-27% -$6.22M 0.01% 826
2025
Q3
$18.8M Buy
947,600
+548,900
+138% +$11.5M 0.01% 814
2025
Q2
$9.94M Buy
398,700
+10,400
+3% +$234K ﹤0.01% 1015
2025
Q1
$9.1M Buy
388,300
+22,900
+6% +$663K 0.01% 917
2024
Q4
$10.2M Buy
365,400
+76,100
+26% +$2.04M ﹤0.01% 900
2024
Q3
$5.9M Sell
289,300
-10,700
-4% -$240K ﹤0.01% 1056
2024
Q2
$8.86M Buy
300,000
+128,200
+75% +$3.68M 0.01% 825
2024
Q1
$5.24M Buy
+171,800
New +$4.85M ﹤0.01% 954

Other funds holding CFLT

IMC Chicago's CFLT Position: Q1 2026 in Review

IMC Chicago sold out of Confluent (CFLT) in Q1 2026, closing a stake of 169,606 shares — an estimated $5.13M sold.

IMC Chicago first reported a position in CFLT in Q1 2024 and held it in 7 quarters. The position peaked at $5.13M in Q4 2025. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • IMC Chicago reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 169,606 Confluent shares in Q1 2026, an estimated $5.13M.
  • IMC Chicago first reported a position in Confluent in Q1 2024 and held it in 7 quarters.
  • IMC Chicago's Confluent position peaked at $5.13M in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.